222 related articles for article (PubMed ID: 29316826)
21. Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways.
Rachakonda V; Gabbert C; Raina A; Bell LN; Cooper S; Malik S; Behari J
PLoS One; 2014; 9(12):e113860. PubMed ID: 25461442
[TBL] [Abstract][Full Text] [Related]
22. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
23. Predictive value of metabolomic biomarkers for cardiovascular disease risk: a systematic review and meta-analysis.
McGranaghan P; Saxena A; Rubens M; Radenkovic J; Bach D; Schleußner L; Pieske B; Edelmann F; Trippel TD
Biomarkers; 2020 Mar; 25(2):101-111. PubMed ID: 31928240
[No Abstract] [Full Text] [Related]
24. Plasma amino acid analysis for diagnosis and amino acid-based metabolic networks.
Kimura T; Noguchi Y; Shikata N; Takahashi M
Curr Opin Clin Nutr Metab Care; 2009 Jan; 12(1):49-53. PubMed ID: 19057187
[TBL] [Abstract][Full Text] [Related]
25. Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling.
Hunter WG; Kelly JP; McGarrah RW; Kraus WE; Shah SH
Curr Heart Fail Rep; 2016 Jun; 13(3):119-31. PubMed ID: 27216948
[TBL] [Abstract][Full Text] [Related]
26. The impact of exercise training on the lipid peroxidation metabolomic profile and respiratory infection risk in older adults.
Silva D; Arend E; Rocha SM; Rudnitskaya A; Delgado L; Moreira A; Carvalho J
Eur J Sport Sci; 2019 Apr; 19(3):384-393. PubMed ID: 30035670
[TBL] [Abstract][Full Text] [Related]
27. Identification of drug targets by chemogenomic and metabolomic profiling in yeast.
Wu M; Zheng M; Zhang W; Suresh S; Schlecht U; Fitch WL; Aronova S; Baumann S; Davis R; St Onge R; Dill DL; Peltz G
Pharmacogenet Genomics; 2012 Dec; 22(12):877-86. PubMed ID: 23076370
[TBL] [Abstract][Full Text] [Related]
28. An overview of metabolomic and proteomic profiling in bipolar disorder and its clinical value.
Ribeiro HC; Zandonadi FDS; Sussulini A
Expert Rev Proteomics; 2023; 20(11):267-280. PubMed ID: 37830362
[TBL] [Abstract][Full Text] [Related]
29. Metabolomic profiling reveals bacterial metabolic adaptation strategies and new metabolites.
Wang H; de Carvalho LPS
Curr Opin Chem Biol; 2023 Jun; 74():102287. PubMed ID: 36948086
[TBL] [Abstract][Full Text] [Related]
30. The role of immune and metabolic biomarkers for improved management of sepsis patients.
Schuetz P; Mueller B
Expert Rev Clin Immunol; 2014 Sep; 10(9):1255-62. PubMed ID: 25069484
[TBL] [Abstract][Full Text] [Related]
31. Serum global metabolomics profiling reveals profound metabolic impairments in patients with MPS IIIA and MPS IIIB.
Fu H; Meadows AS; Pineda RJ; Mohney RP; Stirdivant S; McCarty DM
Metab Brain Dis; 2017 Oct; 32(5):1403-1415. PubMed ID: 28382573
[TBL] [Abstract][Full Text] [Related]
32. Metabolic phenotyping and cardiovascular disease: an overview of evidence from epidemiological settings.
Iliou A; Mikros E; Karaman I; Elliott F; Griffin JL; Tzoulaki I; Elliott P
Heart; 2021 Jul; 107(14):1123-1129. PubMed ID: 33608305
[TBL] [Abstract][Full Text] [Related]
33. Metabolomic and glycomic findings in posttraumatic stress disorder.
Konjevod M; Tudor L; Svob Strac D; Nedic Erjavec G; Barbas C; Zarkovic N; Nikolac Perkovic M; Uzun S; Kozumplik O; Lauc G; Pivac N
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():181-193. PubMed ID: 30025792
[TBL] [Abstract][Full Text] [Related]
34. Translating metabolomics to cardiovascular biomarkers.
Senn T; Hazen SL; Tang WH
Prog Cardiovasc Dis; 2012; 55(1):70-6. PubMed ID: 22824112
[TBL] [Abstract][Full Text] [Related]
35. Exploring disease through metabolomics.
Vinayavekhin N; Homan EA; Saghatelian A
ACS Chem Biol; 2010 Jan; 5(1):91-103. PubMed ID: 20020774
[TBL] [Abstract][Full Text] [Related]
36. Metabolomics in gestational diabetes.
Mao X; Chen X; Chen C; Zhang H; Law KP
Clin Chim Acta; 2017 Dec; 475():116-127. PubMed ID: 29066210
[TBL] [Abstract][Full Text] [Related]
37. Chronic Diseases and Lifestyle Biomarkers Identification by Metabolomics.
Mastrangelo A; Barbas C
Adv Exp Med Biol; 2017; 965():235-263. PubMed ID: 28132183
[TBL] [Abstract][Full Text] [Related]
38. Application of metabolomics based on direct mass spectrometry analysis for the elucidation of altered metabolic pathways in serum from the APP/PS1 transgenic model of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
J Pharm Biomed Anal; 2015 Mar; 107():378-85. PubMed ID: 25656489
[TBL] [Abstract][Full Text] [Related]
39. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.
Zhang AH; Sun H; Han Y; Yan GL; Yuan Y; Song GC; Yuan XX; Xie N; Wang XJ
Anal Chem; 2013 Aug; 85(15):7606-12. PubMed ID: 23845028
[TBL] [Abstract][Full Text] [Related]
40. Metabolomics signature improves the prediction of cardiovascular events in elderly subjects.
Rizza S; Copetti M; Rossi C; Cianfarani MA; Zucchelli M; Luzi A; Pecchioli C; Porzio O; Di Cola G; Urbani A; Pellegrini F; Federici M
Atherosclerosis; 2014 Feb; 232(2):260-4. PubMed ID: 24468136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
